Literature DB >> 31721894

Idiopathic pulmonary fibrosis: accurate diagnosis and early treatment.

António Morais1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31721894      PMCID： PMC7247766          DOI： 10.1590/1806-3713/e20190353

Source DB:  PubMed          Journal:  J Bras Pneumol        ISSN： 1806-3713            Impact factor:   2.624


× No keyword cloud information.
  24 in total

1.  Consensus document for the diagnosis and treatment of idiopathic pulmonary fibrosis: Joint Consensus of Sociedade Portuguesa de Pneumologia, Sociedade Portuguesa de Radiologia e Medicina Nuclear e Sociedade Portuguesa de Anatomia Patológica.

Authors:  C Robalo Cordeiro; P Campos; L Carvalho; S Campainha; S Clemente; L Figueiredo; J M Jesus; A Marques; C Souto-Moura; R Pinto Basto; A Ribeiro; M Serrado; A Morais
Journal:  Rev Port Pneumol (2006)       Date:  2016-02-20

2.  An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.

Authors:  Ganesh Raghu; Bram Rochwerg; Yuan Zhang; Carlos A Cuello Garcia; Arata Azuma; Juergen Behr; Jan L Brozek; Harold R Collard; William Cunningham; Sakae Homma; Takeshi Johkoh; Fernando J Martinez; Jeffrey Myers; Shandra L Protzko; Luca Richeldi; David Rind; Moisés Selman; Arthur Theodore; Athol U Wells; Henk Hoogsteden; Holger J Schünemann
Journal:  Am J Respir Crit Care Med       Date:  2015-07-15       Impact factor: 21.405

3.  Idiopathic pulmonary fibrosis--clinical presentation, outcome and baseline prognostic factors in a Portuguese cohort.

Authors:  F Soares Pires; P Caetano Mota; N Melo; D Costa; J M Jesus; R Cunha; S Guimarães; C Souto-Moura; A Morais
Journal:  Rev Port Pneumol       Date:  2012-07-20

4.  Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.

Authors:  Kevin R Flaherty; Athol U Wells; Vincent Cottin; Anand Devaraj; Simon L F Walsh; Yoshikazu Inoue; Luca Richeldi; Martin Kolb; Kay Tetzlaff; Susanne Stowasser; Carl Coeck; Emmanuelle Clerisme-Beaty; Bernd Rosenstock; Manuel Quaresma; Thomas Haeufel; Rainer-Georg Goeldner; Rozsa Schlenker-Herceg; Kevin K Brown
Journal:  N Engl J Med       Date:  2019-09-29       Impact factor: 91.245

5.  Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function.

Authors:  Carlo Albera; Ulrich Costabel; Elizabeth A Fagan; Marilyn K Glassberg; Eduard Gorina; Lisa Lancaster; David J Lederer; Steven D Nathan; Dominique Spirig; Jeff J Swigris
Journal:  Eur Respir J       Date:  2016-07-28       Impact factor: 16.671

6.  Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.

Authors:  Ganesh Raghu; Kevin J Anstrom; Talmadge E King; Joseph A Lasky; Fernando J Martinez
Journal:  N Engl J Med       Date:  2012-05-20       Impact factor: 91.245

7.  A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.

Authors:  Talmadge E King; Williamson Z Bradford; Socorro Castro-Bernardini; Elizabeth A Fagan; Ian Glaspole; Marilyn K Glassberg; Eduard Gorina; Peter M Hopkins; David Kardatzke; Lisa Lancaster; David J Lederer; Steven D Nathan; Carlos A Pereira; Steven A Sahn; Robert Sussman; Jeffrey J Swigris; Paul W Noble
Journal:  N Engl J Med       Date:  2014-05-18       Impact factor: 91.245

8.  Familial pulmonary fibrosis: a heterogeneous spectrum of presentations.

Authors:  Ana Beatriz Hortense; Marcel Koenigkam Dos Santos; Danilo Wada; Alexandre Todorovic Fabro; Mariana Lima; Silvia Rodrigues; Rodrigo Tocantins Calado; José Baddini-Martinez
Journal:  J Bras Pneumol       Date:  2019-06-10       Impact factor: 2.624

9.  First Data on Efficacy and Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis and Forced Vital Capacity of ≤50 % of Predicted Value.

Authors:  Wim A Wuyts; Martin Kolb; Susanne Stowasser; Wibke Stansen; John T Huggins; Ganesh Raghu
Journal:  Lung       Date:  2016-07-04       Impact factor: 2.584

10.  Safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis in Brazil.

Authors:  Carlos Alberto de Castro Pereira; José Antonio Baddini-Martinez; Bruno Guedes Baldi; Sérgio Fernandes de Oliveira Jezler; Adalberto Sperb Rubin; Rogerio Lopes Rufino Alves; Gilmar Alves Zonzin; Manuel Quaresma; Matthias Trampisch; Marcelo Fouad Rabahi
Journal:  J Bras Pneumol       Date:  2019-09-16       Impact factor: 2.624
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.